NewAmsterdam Pharma
NAMS
NAMS
100 hedge funds and large institutions have $1.28B invested in NewAmsterdam Pharma in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
5.62% more ownership
Funds ownership: 80.02% → 85.64% (+5.6%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
7% less capital invested
Capital invested by funds: $1.38B → $1.28B (-$104M)
Holders
100
Holding in Top 10
5
Calls
$1.09M
Puts
$60K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$10.4M | |
| 3 | +$8.66M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$8.34M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$5.87M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$15.4M | |
| 3 | -$2.49M | |
| 4 |
SCM
Superstring Capital Management
New York
|
-$1.23M |
| 5 |
GC
GMT Capital
Atlanta,
Georgia
|
-$1.04M |